chr10-103089711-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001351169.2(NT5C2):​c.1647C>T​(p.Asp549=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.4 in 1,611,386 control chromosomes in the GnomAD database, including 129,685 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 12616 hom., cov: 30)
Exomes 𝑓: 0.40 ( 117069 hom. )

Consequence

NT5C2
NM_001351169.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.259
Variant links:
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
CNNM2 (HGNC:103): (cyclin and CBS domain divalent metal cation transport mediator 2) This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play an important role in magnesium homeostasis by mediating the epithelial transport and renal reabsorption of Mg2+. Mutations in this gene are associated with renal hypomagnesemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 10-103089711-G-A is Benign according to our data. Variant chr10-103089711-G-A is described in ClinVar as [Benign]. Clinvar id is 380852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.259 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NT5C2NM_001351169.2 linkuse as main transcriptc.1647C>T p.Asp549= synonymous_variant 19/19 ENST00000404739.8
CNNM2NM_017649.5 linkuse as main transcriptc.*12531G>A 3_prime_UTR_variant 8/8 ENST00000369878.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NT5C2ENST00000404739.8 linkuse as main transcriptc.1647C>T p.Asp549= synonymous_variant 19/191 NM_001351169.2 P1P49902-1
CNNM2ENST00000369878.9 linkuse as main transcriptc.*12531G>A 3_prime_UTR_variant 8/81 NM_017649.5 P4Q9H8M5-1

Frequencies

GnomAD3 genomes
AF:
0.405
AC:
61405
AN:
151448
Hom.:
12605
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.388
Gnomad AMI
AF:
0.351
Gnomad AMR
AF:
0.403
Gnomad ASJ
AF:
0.431
Gnomad EAS
AF:
0.475
Gnomad SAS
AF:
0.427
Gnomad FIN
AF:
0.365
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.416
GnomAD3 exomes
AF:
0.413
AC:
103054
AN:
249798
Hom.:
21314
AF XY:
0.414
AC XY:
55862
AN XY:
135000
show subpopulations
Gnomad AFR exome
AF:
0.385
Gnomad AMR exome
AF:
0.414
Gnomad ASJ exome
AF:
0.424
Gnomad EAS exome
AF:
0.475
Gnomad SAS exome
AF:
0.436
Gnomad FIN exome
AF:
0.367
Gnomad NFE exome
AF:
0.408
Gnomad OTH exome
AF:
0.412
GnomAD4 exome
AF:
0.399
AC:
582541
AN:
1459820
Hom.:
117069
Cov.:
37
AF XY:
0.400
AC XY:
290702
AN XY:
726162
show subpopulations
Gnomad4 AFR exome
AF:
0.385
Gnomad4 AMR exome
AF:
0.419
Gnomad4 ASJ exome
AF:
0.421
Gnomad4 EAS exome
AF:
0.413
Gnomad4 SAS exome
AF:
0.438
Gnomad4 FIN exome
AF:
0.366
Gnomad4 NFE exome
AF:
0.396
Gnomad4 OTH exome
AF:
0.407
GnomAD4 genome
AF:
0.405
AC:
61457
AN:
151566
Hom.:
12616
Cov.:
30
AF XY:
0.403
AC XY:
29827
AN XY:
74032
show subpopulations
Gnomad4 AFR
AF:
0.388
Gnomad4 AMR
AF:
0.403
Gnomad4 ASJ
AF:
0.431
Gnomad4 EAS
AF:
0.474
Gnomad4 SAS
AF:
0.426
Gnomad4 FIN
AF:
0.365
Gnomad4 NFE
AF:
0.415
Gnomad4 OTH
AF:
0.419
Alfa
AF:
0.410
Hom.:
16583
Bravo
AF:
0.407
Asia WGS
AF:
0.415
AC:
1441
AN:
3478
EpiCase
AF:
0.405
EpiControl
AF:
0.408

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJan 22, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Hereditary spastic paraplegia 45 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
11
DANN
Benign
0.41
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3740387; hg19: chr10-104849468; COSMIC: COSV58415369; COSMIC: COSV58415369; API